You can purchase shares of Alumis (NASDAQ:ALMS) through any online brokerage.

View our list of the best stock brokerages

Other companies in Alumis’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Phibro Animal Health Corp (NASDAQ:PAHC), Terns Pharmaceuticals Inc (NASDAQ:TERN) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).

Alumis has a consensus price target of $35.27.

The stock price for Alumis (NASDAQ: ALMS) is $23.295 last updated April 8, 2026 at 9:40 AM EDT.

There are no upcoming dividends for Alumis.

Alumis does not have any upcoming earnings scheduled.

There is no upcoming split for Alumis.

Alumis is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.